Animal models of depression: navigating through the clinical fog (Q22252352)

Neuroscience & Biobehavioral Reviews

Europe PubMed Central

title

Animal models of depression: navigating through the clinical fog (English)

0 references

Keith Matthews

1

Keith

Matthews

1 reference

7 February 2023

David Christmas

2

David

Christmas

1 reference

7 February 2023

John Swan

series ordinal

3

author given names

John

author last names

Swan

1 reference

7 February 2023

Eleanor Sorrell

series ordinal

4

author given names

Eleanor

author last names

Sorrell

1 reference

7 February 2023

language of work or name

English

0 references

publication date

January 2005

0 references

published in

0 references

volume

29

0 references

issue

4-5

0 references

page(s)

503-513

0 references

cites work

Pretreatment DST and Hypothalamic-Pituitary-Adrenocortical Function in Depressed Patients and Comparison Groups

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Psychiatric diagnosis in an outpatient population. A comparative study of PSE-Catego and DSM-III.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

National Institute of Mental Health Treatment of Depression Collaborative Research Program

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

The validity of animal models of depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

The corticotropin-releasing hormone test in patients with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Life stress, chronic subclinical symptoms and vulnerability to clinical depression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Stress hormone responses to corticotropin-releasing hormone in substance abusers without severe comorbid psychiatric disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Anhedonia and negative symptomatology in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Untreated short-term course of major depression: a meta-analysis of outcomes from studies using wait-list control groups

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Rodent models of prefrontal cortical function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

"Change the mind and you change the brain": effects of cognitive-behavioral therapy on the neural correlates of spider phobia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Hypothalamic-pituitary-adrenal axis function in patients with chronic depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Social-environmental factors in unipolar depression: comparisons of depressed patients and nondepressed controls

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Effects of inescapable shock upon subsequent escape and avoidance responding

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Alleviation of learned helplessness in the dog

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Subgenual prefrontal cortex abnormalities in mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

The role of corticotropin-releasing factor in the pathogenesis of major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Murine models of polycystic kidney disease: molecular and therapeutic insights

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Do rats have prefrontal cortex? The rose-woolsey-akert program reconsidered

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Childhood trauma associated with smaller hippocampal volume in women with major depression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Antidepressant treatment of depression: a metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Recognising psychiatric symptoms. Relevance to the diagnostic process.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Cortisol, stress and depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

Neurocognitive impairment in drug-free patients with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021

How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial?

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEUBIOREV.2005.03.005

7 January 2021